What is Hydrostasis?
Hydrostasis operates at the forefront of hydration technology, specifically addressing the physiological needs of the aging population. The company's flagship product, the Geca Watch, serves as a sophisticated real-time hydration monitor that utilizes advanced sensor technology to provide personalized coaching. By alerting users to hydration needs before the onset of thirst, the platform effectively mitigates risks associated with dehydration in older adults. With three U.S. patents secured since its inception in 2017, Hydrostasis has established a robust intellectual property moat that distinguishes its wearable hardware from generic fitness trackers. The integration of a dedicated mobile application for personalized health insights further cements its role as a comprehensive digital health solution provider.
How much funding has Hydrostasis raised?
Hydrostasis has raised a total of $64K across 1 funding round:
Debt
$64K
Debt (2021): $64K with participation from PPP
Key Investors in Hydrostasis
PPP
Public-Private Partnership
What's next for Hydrostasis?
With the infusion of this latest capital, Hydrostasis is well-positioned to transition from its current development phase into a broader market expansion strategy. The company is expected to prioritize the commercial scaling of the Geca Watch, potentially targeting partnerships with healthcare providers and assisted living facilities to integrate its technology into standard geriatric care protocols. Future growth will likely hinge on the continued refinement of its sensor algorithms and the potential expansion of its patent portfolio to cover broader physiological monitoring capabilities. As the firm navigates this growth stage, the focus will remain on demonstrating clinical efficacy and driving user adoption through evidence-based health outcomes, ultimately aiming to set a new standard for hydration management in the aging demographic.
See full Hydrostasis company page
